Key facts
- It has raised $11.4M; the latest was Later Stage VC ($8.1M) in Sep 2024.
- Notable investors include Tech Incubator Program for Startup, BonAngels Venture Partners, Shinhan Capital, LB Investment, BNH Investment — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Oncosoft
- ·The full record, as it builds
Funding rounds
No funding rounds for Oncosoft are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Oncosoft
Developer of medical disease treatment software intended to streamline the workflow for radiation oncologists. The company's application utilizes machine learning to automate tasks in radiation therapy, such as treatment site detection and organ contour generation, enabling doctors to dedicate more time to patient care and improve the overall efficiency of radiation therapy.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2019
- Employees
- 25
- Website
- oncosoft.io/
- Ownership
- Privately Held (backing)
Oncosoft doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Oncosoft shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Oncosoft in its N-PORT filings yet. We sweep new filings monthly.